Construction, expression, and activities of L49-sFv-β-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation

Bioconjugate Chemistry

Volumn 8, Issue 4, 1997, Pages 510-519

  Siemers, Nathan O ^a   Kerr, David E ^a   Yarnold, Susan ^a   Stebbins, Mark R ^a   Vrudhula, Vivekananda M ^a   Hellström, Ingegerd ^a   Hellström, Karl Erik ^a   Senter, Peter D ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANTIBIOTICS; ANTIGENS; BLOOD; CHAINS; CHEMICAL ACTIVATION; CLONE CELLS; CLONING; ESCHERICHIA COLI; GENE ENCODING; POLYMERASE CHAIN REACTION; PURIFICATION; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; TRANSCRIPTION; TUMORS;

ANTIBODY BINDING; ENTEROBACTER CLOACAE; EXPRESSION SYSTEM; FUSION PROTEINS; NUDE MICE; PRODRUG ACTIVATION; PRODRUGS; SINGLE-CHAIN ANTIBODIES; SOLUBLE EXPRESSION; Β-LACTAMASE;

MONOCLONAL ANTIBODIES;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; MUS MUSCULUS;

EID: 0031194865     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9700751     Document Type: Article

References (45)

1. Senter, P. D., Wallace, P. M., Svensson, H. P., Vrudhula, V. M., Kerr, D. E., Hellström, I., and Hellström, K. E. (1993) Generation of cytotoxic agents by targeted enzymes. Bioconjugate Chem. 4, 3-9.
2. Jungheim, L. N., and Shepherd, T. A. (1994) Design of anticancer prodrugs: substrates for antibody targeted enzymes. Chem. Rev. 94, 1553-1566.
3. Bagshawe, K. D., Sharma, S. K., Springer, C. J., and Rogers, G. T. (1994) Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects. Ann. Oncol. 5, 879-891.
4. Bosslet, K., Czech, J., and Hoffmann, D. (1994) Tumor-selective prodrug activation by fusion protein-mediated catalysis. Cancer Res. 54, 2151-2159.
5. Wallace, P. M., MacMaster, J. F., Smith, V., Kerr, D. E., Senter, P. D., and Cosand, W. L. (1994) Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine. Cancer Res. 54, 2719-2723.
6. Svensson, H. P., Vrudhula, V. M., Emswiler, J. E., MacMaster, J. F., Cosand, W. L., Senter, P. D., and Wallace, P. M. (1995) In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody β-lactamase conjugates. Cancer Res. 55, 2357-2365.
7. Springer, C. J., Bagshawe, K. D., Sharma, S. K., Searle, F., Boden, J. A. Antoniw, P., Burke, P. J., Rogers, G. T., Sherwood, R. F., and Melton, R. G. (1991) Abalation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. Eur. J. Cancer 27, 1361-1366.
8. Meyer, D. L., Jungheim, L. N., Law, K. L., Mikolajczyk, S. D., Shepherd, T. A., Mackensen, D. G., Briggs, S. L., and Starling, J. J. (1993) Site-specific prodrug activation by antibody-β-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models. Cancer Res. 53, 3956-3963.
9. Eccles, S. A., Court, W. J., Box, G. A., Dean, C. J., Melton, R. G., and Springer, C. J. (1994) Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185. Cancer Res. 54, 5171-5177.
10. Kerr, D. E., Schreiber, G. L., Vrudhula, V. M., Svensson, H. P., Hellström, I., Hellström, K. E., and Senter, P. D. (1995) Regressions and cures of melanoma xenografts following treatment with monoclonal antibody β-lactamase conjugates in combination with anticancer prodrugs. Cancer Res. 55, 3558-3563.
11. Woodbury, R. G., Brown, J. P., Yeh, M.-Y., Hellström, I., and Hellström, K. E. (1980) Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc. Natl. Acad. Sci. U.S.A. 77, 2183-2187.
12. Brown, J. P., Nishiyama, K., Hellström, I., and Hellström, K. E. (1981) Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J. Immunol. 127, 539-545.
13. Brown, J. P., Woodbury, R. G., Hart, C. E., Hellström, I., and Hellström, K. E. (1981) Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc. Natl. Acad. Sci. U.S.A. 78, 539-543.
14. Rose, T. M., Plowman, G. D., Teplow, D. B., Dreyer, W. J., Hellström, K. E., and Brown, J. P. (1986) Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc. Natl. Acad. Sci. U.S.A. 83, 1261-1265.
15. Mikolajczyk, S. D., Meyer, D. L., Starling, J. J., Law, K. L., Rose, K., Dufour, B., and Offord, R. E. (1994) High yield, site-specific coupling of N-terminally modified β-lactamase to a proteolytically derived single-sulfhydryl murine Fab′. Bioconjugate Chem. 5, 636-646.
16. Werlen, R. C., Lankinen, M., Rose, K., Blakey, D., Shuttleworth, H., Melton, R., and Offord, R. E (1994). Site-specific conjugation of an enzyme and an antibody fragment. Bioconjugate Chem. 5, 411-417.
17. Werlen, R. C., Lankinen, M., Smith, A., Chernushevich, I., Standing, K. G., Blakey, D. C., Shuttleworth, H., Melton, R. G., Offord, R. E., and Rose, K. (1995) Site-specific immunoconjugates. Tumor Targeting 1, 251-258.
18. Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H. H., Shuermann, M., and Seemann, G. (1992) Molecular and functional characterization of a fusion protein suited for tumor specific prodrug activation. Br. J. Cancer 65, 234-238.
19. Goshorn, S. C., Svensson, H. P., Kerr, D. E., Somerville, J. E., Senter, P. D., and Fell, H. P. (1993) Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to β-lactamase. Cancer Res. 53, 2123-2127.
20. Rodrigues, M. L., Presta, L. G., Kotts, C. F., Wirth, C., Mordenti, J., Osaka, G., Wong, W. L. T., Nuijens, A., Blackburn, B., and Carter, P. (1995) Development of a humanized disulfide-stabilized anti-p185 HER2 Fv-β-lactamase fusion protein protein for activation of a cephalosporin doxorubicin prodrug. Cancer Res. 55, 63-70.
21. Galleni, M., Lindberg, F., Normark, S., Cole, S., Honore, N., Joris, B., and Frère, J. M. (1988) Sequence and comparative analysis of three Enterobacter cloacae ampC beta-lactamase genes and their products. Biochem. J. 250, 753-760.
22. Siemers, N. O., Yelton, D. E., Bajorath, J., and Senter, P. D. (1996) Modifying the specificity and activity of the Enterobacter cloacae P99 β-lactamase by mutagenesis within an M13 phage vector. Biochemistry 35, 2104-2111.
23. Svensson, H. P., Wallace, P. M., and Senter, P. D. (1994) Synthesis and characterization of monoclonal antibody-β-lactamase conjugates. Bioconjugate Chem. 5, 262-267.
24. Vrudhula, V. M., Svensson, H. P., Kennedy, K. A., Senter, P. D., and Wallace, P. M. (1993) Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-β-lactamase conjugates. Bioconjugate Chem. 4, 334-340.
25. Everett, J. L., and Ross, W. C. R. (1949) Aryl-2-halo-genoalkylamines. Part II. J. Chem. Soc., 1972-1983.
26. Yeh, M. Y., Hellström, I., Brown, J. P., Warner, G. A., Hansen, J. A., and Hellström, K. E. (1979) Cell surface antigens of human melanoma identified by monoclonal antibody. Proc. Natl. Acad. Sci. U.S.A. 76, 2927-2931.
27. Trucco, M., and dePetris, S. (1981) Determination of equilibrium binding parameters of monoclonal antibodies specific for cell surface antigens. Immunological Methods (I. Lefkovits and B. Pernis, Eds.) pp 1-26, Academic Press, New York.
28. Alemany, R., Rosa Vila, M., Franci, C., Egea, G., Real, R. X., and Thomson, T. M. (1993) Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells. J. Cell Sci. 104, 1155-1162.
29. Food, M. R., Rothenberger, S., Gabathuler, R., Haidl, I. D., Reid, G., and Jefferies, W. A. (1994) Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein. J. Biol. Chem. 269, 3034-3040.
30. Cockett, M. I., Bebbington, C. R., and Yarranton, G. I. (1990) High level expression of tissue inhibitor of metallo-proteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology 8, 662-667.
31. Stephens, P. E., and Cockett, M. I. (1989) The construction of a highly efficient and versatile set of mammalian expression vectors. Nucleic Acids Res. 17, 7110.
32. Baker, E. N., Baker, H. M., Smith, C. A., Stebbins, M. R., Kahn, M., Hellström, K. E., and Hellström, I. (1992) Human melanotransferrin (p97) has only one functional binding site. FEBS Lett. 298, 215-218.
33. Jones, S. T., and Bendig, M. M. (1991) Rapid PCR-cloning of full-length mouse immunoglobulin variable regions. Biotechnology 9, 88-92.
34. Whitlow, M., Bell, B. A., Feng, S-L., Fipula, D., Hardman, K. D., Hubert, S. L., Rollence, M. L., Wood, F. F., Schott, M. E., Milenic, D. E., Yokota, T., and Schlom, J. (1993) An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng. 6, 989-995.
35. Cartwright, S. J., and Waley, S. G. (1984) Purification of β-lactamases by affinity chromatography on phenylboronic acid-agarose. Biochem. J. 221, 505-512.
36. Svensson, H. P., Kadow, J. F., Vrudhula, V. M., Wallace, P. M., and Senter, P. D. (1992) Monoclonal antibody-β-lactamase conjugates for the activation of a cephalosporin mustard prodrug. Bioconjugate Chem. 3, 176-181.
37. O'Callaghan, D. E., Morris, A., Kirby, S., and Shingler, A. H. (1972) Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1, 283-288.
38. Plückthun, A. (1992) Mono-and bivalent antibody fragments produced in E. coli: engineering, folding, and antigen binding. Immunol. Rev. 130, 151-188.
39. Adamczyk, M., Gebler, J. C., and Mattingly, P. G. (1996) Characterization of protein-hapten conjugates. 2. Electro-spray mass spectrometry of bovine serum albumin-hapten conjugates. Bioconjugate Chem. 7, 475-481.
40. Chang, T. K., Jackson, D. Y., Burnier, J. P., and Wells, J. A (1994) Subtiligase: a tool for semisynthesis of proteins. Proc. Natl. Acad. Sci. U.S.A. 91, 12544-12548.
41. Jackson, D. Y., Burnier, J., Quan, C., Stanley, M., Tom, J., and Wells, J. A. (1994) A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues. Science 266, 243-247.
42. Schwarz, A., Wandrey, C., Bayer, E. A., and Wilchek, M. (1991) Enzymatic C-terminal biotinylation of proteins. Methods Enzymol. 184, 160-162.
43. Rose, K., Vilaseca, L. A., Werlen, R., Meunier, A., Fisch, I., Jones, R. M. L., and Offord, R. E. (1991) Preparation of well-defined protein conjugates using enzyme-assisted reverse proteolysis. Bioconjugate Chem. 2, 154-159.
44. Kerr, D. E., Garrigues, U. S., Wallace, P. M., Hellström, K. E., Hellström, I., and Senter, P. D. (1993) Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate. Bioconjugate Chem. 4, 353-357.
45. Rogers, G. T., Burke, P. J., Sharma, S. K., Koodie, R., and Boden, J. A. (1995) Plasma clearance of an antibody-enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo. Br. J. Cancer 72, 1357-1363.